3,5-Dimethyl-4-isoxazoyl selenocyanate as promising agent for the treatment of Leishmania infantum-infected mice
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Acta Tropica
- Vol. 215, 105801
Abstract
No abstract availableKeywords
Funding Information
- Universidad de Navarra
- Universidad de Navarra
This publication has 45 references indexed in Scilit:
- Leishmaniasis Worldwide and Global Estimates of Its IncidencePLOS ONE, 2012
- A novel mechanism for an old drug: Amphotericin B in the treatment of visceral leishmaniasisBiochemical and Biophysical Research Communications, 2011
- Selenocyanates and diselenides: A new class of potent antileishmanial agentsEuropean Journal of Medicinal Chemistry, 2011
- Nanonization strategies for poorly water-soluble drugsDrug Discovery Today, 2011
- Principles of early drug discoveryBritish Journal of Pharmacology, 2011
- Antileishmanial activity of imidothiocarbamates and imidoselenocarbamatesParasitology Research, 2010
- Multiple Peaking Phenomena in Pharmacokinetic DispositionClinical Pharmacokinetics, 2010
- Improved targeting of antimony to the bone marrow of dogs using liposomes of reduced sizeInternational Journal of Pharmaceutics, 2006
- Prediction of human absorption of natural compounds by the non-everted rat intestinal sac modelEuropean Journal of Medicinal Chemistry, 2006
- Frog intestinal sac: A new in vitro method for the assessment of intestinal permeability**Part of this article was presented at the European Conference on Drug Delivery and Pharmaceutical Technology, Sevilla, Spain, May 10–12, 2004.Journal of Pharmaceutical Sciences, 2004